Publication Information Number of Citations Address
1 Varol,  I; Kaplan,  O; Erdoğar, N; Öncül, S; Nielsen, T.T; Ercan, A; Bilensoy, E; Çelebier M, “Q-TOF LC/MS-based Untargeted Metabolomics Approach to Evaluate the Effect of Folate-Conjugated Cyclodextrins on Triple-Negative Breast Cancer Cells”, Current Pharmaceutical Analysis, (E-pub Ahead of Print), 2020wos wos 0 hacettepe
2 Varan, C; Anceschi, A; Sevli, S; Bruni, N; Giraudo, L; Bilgiç, E; Korkusuz, P; İskit, A.B; Trotta, F; Bilensoy, E, “Preparation and Characterization of Cyclodextrin Nanosponges for Organic Toxic Molecule Removal”, International Journal of Pharmaceutics, Vol.585, 119485 , 2020wos wos 1 hacettepe
3 Ünal, S; Aktaş, Y; Benito, J.M; Bilensoy, E, “Cyclodextrin nanoparticle bound oral camptothecin for colorectal cancer: Formulation development and optimization”, International Journal of Pharmaceutics, Vol.584, 119468 , 2020wos wos 1 hacettepe
4 Varan, C; Şen, M; Sandler, N; Aktaş, Y; Bilensoy, E, “Mechanical characterization and ex vivo evaluation of anticancer and antiviral drug printed bioadhesive film for the treatment of cervical cancer”, Eur J Pharm Sci., Vol.130, P.114-123, 2019wos wos 4 hacettepe
5 Ercan, A; Çelebier, M; Varan, G; Öncü, S; Nenni, M; Kaplan, O; Bilensoy, E, “Global omics strategies to investigate the effect of cyclodextrin nanoparticles on MCF-7 breast cancer cells”, Eur J Pharm Sci., Vol.123, P.377-386, 2018wos wos 0 hacettepe
6 Varan, G; Patrulea, V; Borchard, G; Bilensoy, E, “Cellular interaction and tumoral penetration properties of cyclodextrin nanoparticles on 3D breast tumor model”, Nanomaterials (Basel), Vol.8, Is.2, pii.E67, 2018wos wos 4 hacettepe
7 Erdoğar, N; Esendağlı,G; Nielsen, TT; Esendağlı-Yılmaz, G; Yöyen-Ermiş, D; Erdoğdu, B; Sargon, MF; Eroğlu, H; Bilensoy, E, “Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer”, J Drug Target., Vol.26, Is.1, P.66-74, 2018wos wos 4 hacettepe
8 Erdoğar, N; Akkın, S; Bilensoy, E, “Nanocapsules for Drug Delivery: An Updated Review of the Last Decade”, Recent Pat Drug Deliv Formul., Vol.12, Is.4, P.252-266, 2018wos wos 0 hacettepe
9 Karabey-Akyurek, Y; Gurcay, AG; Gurcan, O; Turkoglu, OF; Yabanoglu-Ciftci, S; Eroglu, H; Sargon, MF; Bilensoy, E; Oner, L, “Localized delivery of methylprednisolone sodium succinate with polymeric nanoparticles in experimental injured spinal cord model”, Pharm Dev Technol., Vol.22, Is.8, P.972-981, 2017wos wos 4 hacettepe
10 Varan, G; Varan, C; Erdoğar, N; Bilensoy, E, “Amphiphilic cyclodextrin nanoparticles “, Int J Pharm, Vol.531, Is.2, P.457-459, 2017wos wos 17 hacettepe
11 Varan, C; Wickström, H; Sandler, N; Aktaş, Y; Bilensoy, E, “Inkjet printing of antiviral PCL nanoparticles and anticancer cyclodextrin inclusion complexes on bioadhesive film for cervical administration”, Int J Pharm, Vol.531, Is.2, P.701-713, 2017wos wos 9 hacettepe
12 Karabey-Akyurek, Y; Nemutlu, E; Bilensoy, E; Oner, L, “An Improved and Validated HPLC Method for the Determination of Methylprednisolone Sodium Succinate and its Degradation Products in Nanoparticles”, CURR PHAR A, Vol.13, Is.2, P.162-168, 2017wos wos 2 hacettepe
13 Varan, C; E; Bilensoy, “Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment”, Beilstein J Nanotechnol., Vol.8,  P.1446-1456, 2017wos wos 2 hacettepe
14 Erdoğar, N; Varan, G; Bilensoy, E, “Amphiphilic cyclodextrin derivatives for targeted drug delivery to tumors”, Curr Top Med Chem., Vol.17, Is.13, P.1521-1528, 2017wos wos 8 hacettepe
15 Varan, G; Benito, JM; Mellet, CO; Bilensoy, E, “Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery “, Beilstein J Nanotechnol., Vol.8, P.1457-1468, 2017wos wos 4 hacettepe
16 Varan, G; Oncul, S; Ercan, A; Benito, JM; Mellet, CO; Bilensoy, E, “Cholesterol-Targeted Anticancer and Apoptotic Effects of Anionic and Polycationic Amphiphilic Cyclodextrin Nanoparticles”, J PHARM SCI, Vol.105, Is.10, P.3172-3182, 2016wos wos 6 hacettepe
17 Erdogar, N; Esendagli, G; Nielsen, TT; Sen, M; Oner, L; Bilensoy, E, “Design and optimization of novel paclitaxel-loaded folate-conjugated amphiphilic cyclodextrin nanoparticles”, INT J PHARM, Vol.127, Is.1, P.375-390, 2016wos wos 12 hacettepe
18 Aktas, Y; Yenice, K; Bilensoy, E; Hincal, AA, “Amphiphilic cyclodextrins as enabling excipients for drug delivery and for decades of scientific collaboration: Tribute to a distinguished scientist, French representative and friend – A historical perspective”, J DRUG DELI, Vol.30, Is.0, P.261-265, 2015wos wos 4 hacettepe
19 Erdogar, N; Iskit, AB; Eroglu, H; Sargon, MF; Mungan, NA; Bilensoy, E, “Antitumor Efficacy of Bacillus Calmette-Guerin Loaded Cationic Nanoparticles for Intravesical Immunotherapy of Bladder Tumor Induced Rat Model”, J NANOSCI N, Vol.15, Is.12, P.10156-10164, 2015wos wos 7 hacettepe
20 Unal, H; d’Angelo, I; Pagano, E; Borrelli, F; Izzo, A; Ungaro, F; Quaglia, F; Bilensoy, E, “Core-shell hybrid nanocapsules for oral delivery of camptothecin: formulation development, in vitro and in vivo evaluation”, J NANOPAR R, Vol.17, Is.1, P.0-0, 2015wos wos 14 hacettepe
21 Unal, H; Ozturk, N; Bilensoy, E, “Formulation development, stability and anticancer efficacy of core-shell cyclodextrin nanocapsules for oral chemotherapy with camptothecin”, BEIL J OR C, Vol.11, Is.0, P.204-212, 2015wos wos 16 hacettepe
22 Bilensoy, E, “Amphiphilic cyclodextrin nanoparticles for effective and safe delivery of anticancer drugs”, Adv Exp Med Biol., Vol.822, P.201, 2015wos wos 6 hacettepe
23 Varan, C; Bilensoy, E, “Development of implantable hydroxypropyl-beta-cyclodextrin coated polycaprolactone nanoparticles for the controlled delivery of docetaxel to solid tumors”, J INCL P MA, Vol.80, Is.1, P.9-15, 2014wos wos 2 hacettepe
24 Vranic, E; Grizic, D; Planinsek, O; Srcic, S; Bilensoy, E, “Binary, ternary and microencapsulated celecoxib complexes with beta-cyclodextrin formulated via hydrophilic polymers”, J INCL P MA, Vol.80, Is.1, P.139-146, 2014wos wos 1 hacettepe
25 Erdogar, N; Iskit, AB; Eroglu, H; Sargon, MF; Mungan, NA; Bilensoy, E, “Cationic core-shell nanoparticles for intravesical chemotherapy in tumor-induced rat model: Safety and efficacy”, INT J PHARM, Vol.127, Is.1, P.1-9, 2014wos wos 4 hacettepe
26 Erdogar, N; Iskit, AB; Mungan, NA; Bilensoy, E, “Prolonged retention and in vivo evaluation of cationic nanoparticles loaded with Mitomycin C designed for intravesical chemotherapy of bladder tumours”, J MICROENC, Vol.29, Is.6, P.576-582, 2012wos wos 7 hacettepe
27 Karakas, FP; Karakas, A; Boran, C; Turker, AU; Yalcin, FN; Bilensoy, E, “The evaluation of topical administration of Bellis perennis fraction on circular excision wound healing in Wistar albino rats”, PHARM BIOL, Vol.50, Is.8, P.1031-1037, 2012wos wos 8 hacettepe
28 Bilensoy, E; Moroy, P; Cirpanh, Y; Bilensoy, T; Calis, S; Mollamahmutoglu, L, “A double-blind placebo-controlled study of 5-fluorouracil:cyclodextrin complex loaded thermosensitive gel for the treatment of HPV induced condyloma”, J INCL P MA, Vol.69, Is.3, P.309-313, 2011wos wos 2 hacettepe
29 Cirpanli, Y; Allard, E; Passirani, C; Bilensoy, E; Lemaire, L; Calis, S; Benoit, JP, “Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model”, INT J PHARM, Vol.403, Is.1, P.201-206, 2011wos wos 36 hacettepe
30 Rouf, MA; Vural, I; Bilensoy, E; Hincal, A; Erol, DD, “Rapamycin-cyclodextrin complexation: improved solubility and dissolution rate”, J INCL P MA, Vol.70, Is.1, P.167-175, 2011wos wos 10 hacettepe
31 Yavuz, B; Bilensoy, E; Vural, I; Sumnu, M, “Alternative oral exemestane formulation: Improved dissolution and permeation”, INT J PHARM, Vol.398, Is.1, P.137-145, 2010wos wos 19 hacettepe
32 Cirpanli, Y; Yerlikaya, F; Ozturk, K; Erdogar, N; Launay, M; Gegu, C; Leturgez, T; Bilensoy, E; Calis, S; Capan, Y, “Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(epsilon-caprolactone) and chitosan nanoparticles”, PHARMAZIE, Vol.65, Is.12, P.867-870, 2010wos wos 4 hacettepe
33 Erdoğar, N; Mungan, A; Bilensoy, E, “Preparation and characterization of cationic nanoparticles loaded with Mitomycin C by double emulsion and ionotropic gelation techniques”, Journal of controlled release, Vol.148, Is.1, P.e78-79, 2010wos wos 5 hacettepe
34 Cirpanli, Y; Bilensoy, E; Doğan, AL; Çalış, S, “Development of polymeric and cyclodextrin nanoparticles for camptothecin delivery.”, Journal of controlled release, Vol.148, Is.1, P.e21-23, 2010wos wos 10 hacettepe
35 Yavuz, B; Sarısözen, C; Vural, I; Bilensoy, E; Sumnu, M, “An alternative cyclodextrin based formulation for oral anticancer drug exemestane: In vitro and cell culture studies”, Journal of controlled release, Vol.148, Is.1, P.e83-84, 2010wos wos 3 hacettepe
33 Hıncal, AA; Eroğlu, H; Bilensoy, E, “Safety and efficacy of amphiphilic cyclodextrins for drug delivery”, Drug Metab. Rev., Vol.42, Is.1, P.12-13, 2010wos wos  93 hacettepe
36 Bilensoy, E, “Cationic nanoparticles for cancer therapy”, EXP OP DR D, Vol.7, Is.7, P.795-809, 2010wos wos 26 hacettepe
37 Bilensoy, E; Hincal, AA, “Recent advances and future directions in amphiphilic cyclodextrin nanoparticles”, EXP OP DR D, Vol.6, Is.11, P.1161-1173, 2009wos wos 35 hacettepe
38 Cirpanli, Y; Bilensoy, E; Dogan, AL; Calis, S, “Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery”, EUR J PH B, Vol.73, Is.1, P.82-89, 2009wos wos 54 hacettepe
39 Cakmak, A; Cirpanli, Y; Bilensoy, E; Yorganci, K; Calis, S; Saribas, Z; Kaynaroglu, V, “Antibacterial activity of triclosan chitosan coated graft on hernia graft infection model”, INT J PHARM, Vol.381, Is.2, P.214-219, 2009wos wos 17 hacettepe
40 Bilensoy, E; Sarisozen, C; Esendagli, G; Dogan, AL; Aktas, Y; Sen, M; Mungan, NA, “Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors”, INT J PHARM, Vol.371, Is.1, P.170-176, 2009wos wos 56 hacettepe
41 Bilensoy, E; Gurkaynak, O; Dogan, AL; Hincal, AA, “Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery”, INT J PHARM, Vol.347, Is.1, P.163-170, 2008wos wos 76 hacettepe
42 Yenice, I; Mocan, MC; Palaska, E; Bochot, A; Bilensoy, E; Vural, I; Irkec, M; Hincal, AA, “Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea”, EXP EYE RES, Vol.87, Is.3, P.162-167, 2008wos wos 42 hacettepe
43 Bilensoy, E; Gurkaynak, O; Ertan, M; Sen, M; Hincal, AA, “Development of nonsurfactant cyclodextrin nanoparticles loaded with anticancer drug paclitaxel”, J PHARM SCI, Vol.97, Is.4, P.1519-1529, 2008wos wos 58 hacettepe
44 Bilensoy, E, “Nanoparticulate Delivery Systems Based on Amphiphilic Cyclodextrins”, J BIOMED NA, Vol.4, Is.3, P.293-303, 2008wos wos 15 hacettepe
45 Bilensoy, E; Cirpanli, Y; Sen, M; Dogan, AL; Calis, S, “Thermosensitive mucoadhesive gel formulation loaded with 5-Fu: cyclodextrin complex for HPV-induced cervical cancer”, J INCL P MA, Vol.57, Is.1, P.363-370, 2007wos wos 44 hacettepe
46 Bilensoy, E; Dogan, L; Sen, M; Hincal, A, “Complexation behavior of antiestrogen drug tamoxifen citrate with natural and modified beta-cyclodextrins”, J INCL P MA, Vol.57, Is.1, P.651-655, 2007wos wos 23 hacettepe
47 Sarısözen, C; Aktas, Y; Mungan, A; Bilensoy, E, “Bioadhesive coated poly-epsilon-caprolactone nanoparticles loaded with Mitomycin C for the treatment of superficial bladder tumors”, EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, Vol.32, Is. 1, P.S36, 2007 hacettepe
48 Yavuz, B; Bilensoy, E; Şumnu, M, “Bioavailability file: Exemestane”, Fabad Journal of Pharmaceutical Sciences, Vol.32, Is. 2, P.79-89, 2007 4 hacettepe
49 Bilensoy, E; Rouf, MA; Vural, I; Sen, M; Hincal, AA, “Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: beta-cyclodextrin complex”, AAPS PHARMS, Vol.7, Is.2, P.0-0, 2006 wos 111 hacettepe
50 Bilensoy, E, “Targeted nanoparticles for cancer therapy”, FEBS JOURNAL, Vol.273, P.35, 2006 hacettepe
51 Bilensoy, E; Rouf, MA; Vural, I; Hıncal AA, “Thermosensitive vaginal gel formulation for the controlled release of clotrimazole via complexation to beta-cyclodextrin”, JOURNAL OF CONTROLLED RELEASE, Vol.116, Is.2, P.E107-109, 2006  8 hacettepe
52 Yavuz, B; Bilensoy, E; Şumnu M, “Analytical method validation for HPLC assay of oral anticancer drug exemestane”, Fabad Journal of Pharmaceutical Sciences, Vol.32, Is.1, P.15-22, 2006 3 hacettepe
53 Hincal, AA;Bilensoy, E, “Formulation of poorly water soluble drugs with amphiphilic beta cyclodextrins”, EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, Vol.28, P.S8-S9, 2006 hacettepe
54 Memisoglu-Bilensoy, E; Doğan, AL; Hıncal AA, “Cytotoxic evaluation of injectable cyclodextrin nanoparticles”, Journal of Pharmacy and Pharmacology, Vol.58, Is.5, P.585-589, 2006  31 hacettepe
55 Memisoglu-Bilensoy, E; Hincal, AA, “Sterile, injectable cyclodextrin nanoparticles: Effects of gamma irradiation and autoclaving”, INT J PHARM, Vol.311, Is.1, P.203-208, 2006wos wos 44 hacettepe
56 Memisoglu-Bilensoy, E; Sen, M; Hincal, AA, “Effect of drug physicochemical properties on in vitro characteristics of amphiphilic cyclodextrin nanospheres and nanocapsules”, JOURNAL OF MICROENCAPSULATION, Vol.23, Is.1, P.59-68, 2006wos wos 26 hacettepe
57 Memisoglu-Bilensoy, E; Vural, L; Bochot, A; Renoir, JM; Duchene, D; Hincal, AA, “Tamoxifen citrate loaded amphiphilic β-cyclodextrin nanoparticles: In vitro characterization and cytotoxicity”, J CONTR REL, Vol.104, Is.3, P.489-496, 2005 107 hacettepe
58 Memisoglu-Bilensoy, E, “Tamoxifen citrate loaded amphiphilic β-cyclodextrin nanoparticles: System development and evaluation”, European Journal of Pharmaceutical Sciences, Vol.25, SUPPL. 1, P.54-56, 2005 2 hacettepe
59 Vural, I; Memisoglu-Bilensoy, E; Renoir, JM; Bochot, A; Duchene, D; Hincal, AA, “Transcription efficiency of tamoxifen citrate-loaded β-cyclodextrin nanoparticles”, Journal of Drug Delivery Science and Technology, Vol.15, Is.5, P.339-342, 2005 9 hacettepe
60 Memisoglu, E; Vural, L; Bochot, A; Renoir, JM; Duchene, D; Hincal, AA, “Non-surfactant nanospheres of progesterone inclusion complexes with amphiphilic β-cyclodextrins”, International Journal of Pharmaceutics, Vol.251, Is.1-2, P.143-153, 2003 46 hacettepe
61 Memisoglu, E; Bochot, A; Özalp, M; Şen, M; Duchene, D; Hincal, AA, “Direct formation of nanospheres from amphiphilic β-cyclodextrin inclusion complexes”, Pharmaceutical Research, Vol.20, Is.1, P.117-125, 2003 80 hacettepe
62 Ringard-Lefebvre, C; Bochot, A; Memisoglu, E; Charon, D; Duchene, D; Baszkin, A, “Effect of spread amphiphilic β-cyclodextrins on interfacial properties of the oil/water system”, Colloids and Surfaces B: Biointerfaces, Vol.25, Is.2, P.109-117, 2002 38 hacettepe
63 Memisoglu, E; Bochot, A; En, M; Charon, D; Duchene, D; Hincal, AA, “Amphiphilic β-cyclodextrins modified on the primary face: Synthesis, characterization, and evaluation of their potential as novel excipients in the preparation of nanocapsules”, Journal of Pharmaceutical Sciences, Vol.91, Is.5, P.1214-1224, 2002 63 hacettepe
64 Memisoglu, E; Öner, F; Ayhan, A; Başaran, I; Hincal, AA, “In vivo evaluation for rhGM-CSF wound-healing efficacy in topical vehicles”, Pharmaceutical Development and Technology, Vol.2, Is.2, P.171-180, 1997 10 hacettepe